XML 63 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Operating activities:    
Net income (loss) $ (2,837) $ (3,044)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 9,689 4,797
Share-based compensation 853 613
Amortization of deferred financing costs 421 330
Amortization of ground lease 54 55
Equity in loss from joint venture 3,596 0
Deferred income tax benefit 2,673 (452)
Other 62 0
Changes in assets and liabilities:    
Restricted cash, net 372 355
Hotel receivables (3,876) (4,112)
Prepaid expenses and other assets (1,842) (219)
Accounts payable and accrued expenses (332) 1,322
Advance deposits 1,762 538
Net cash provided by (used in) operating activities 10,595 183
Investing activities:    
Acquisition of hotel properties 0 (37,193)
Improvements and additions to hotel properties (17,005) (9,644)
Deposit on hotel properties (3,000) (13,500)
Purchase of corporate office equipment, computer software, and furniture 0 (13)
Restricted cash, net 282 (2,085)
Net cash used in investing activities (19,723) (62,435)
Financing activities:    
Gross proceeds from issuance of common shares 32,421 0
Gross proceeds from issuance of preferred shares 0 125,000
Payment of offering costs - common and preferred shares (548) (4,023)
Payment of deferred financing costs (594) (722)
Contributions from non-controlling interest 0 95
Borrowings under senior credit facility 70,000 0
Repayments under senior credit facility (70,000) 0
Proceeds from mortgage debt 93,000 67,000
Repayments of mortgage debt (133,477) (180)
Repurchase of common shares (319) (140)
Distributions - common shares/units (6,219) (4,908)
Distributions - preferred shares (4,456) 0
Net cash (used in) provided by financing activities (20,192) 182,122
Net change in cash and cash equivalents (29,320) 119,870
Cash and cash equivalents, beginning of year 65,684 220,722
Cash and cash equivalents, end of period $ 36,364 $ 340,592